Expert Insights On Cell Line Development

81. An Analysis Of The Gene Therapy Viral Vector Landscape 4/21/2021

    Over the last five years, multiple gene therapies have been approved by regulatory agencies and a bolus of late-stage pipeline assets are approaching the market. However, as the first gene therapies began to post early wins, several challenges have emerged. This article discusses the landscape of the viral vector sector.

82. Culture Media Market Growth Drives Demand For New & Better Technologies 7/6/2020

    With a rise in bioprocessing demand, the market for cell culture media—an essential component of bioprocessing—has also seen a surge in the last few years. This column takes a deep look at the market as measured in BioPlan’s 2020 17th Annual Report and Survey of Biopharmaceutical Manufacturing,